Tuesday, November 29, 2022

FDA’s failure to adequately oversee vaccine clinical trials is endangering public health

 A paper has revealed that the Food and Drug Administration (FDA) exhibited a lax attitude toward safety concerns about the Wuhan coronavirus (COVID-19) vaccines, which the agency later approved.

  • The paper by Australian investigative journalist Maryanne Demasi was published Nov. 16 in BMJ Investigation.
  • She revealed the FDA exhibited lax attitude regarding the oversight of COVID vaccine and drug trials
  • Only nine out of 153 Pfizer trial sites were subject to FDA inspection before licensing the mRNA vaccine
  • Similarly, only 10 out of 99 Moderna trial sites and five of 73 remdesivir vaccine sites were inspected

Former FDA advisor accuses agency of ‘endangering public health’

  • David Gortler, a former senior advisor to the FDA commissioner, remarked that the regulator is “endangering [public health] by not being candid about the violations uncovered during clinical trial site inspections.”
  • The FDA paused site inspections during the peak of COVID-19 pandemic restrictions between March and July 2020, with only “mission-critical inspections” being carried out.
  • During a pandemic, the FDA could’ve put inspectors in hazmat suits if they wanted to, but they didn’t.

https://www.naturalnews.com/2022-11-28-fda-oversight-vaccine-clinical-trials-endangering-public-health.html

No comments: